[

zydus cadila news

]

Latest from zydus cadila

Zydus Cadila begins supply of its anti-Covid vaccine to Centre

ZyCoV-D, which was cleared by the DCGI in August last year, is a needle-less vaccine, and will be administered in three doses.

A doctor being inoculated with a booster dose of Covid-19 vaccine, at Ganga Ram Hospital, in New Delhi. (Amal KS/HT Photo)
A doctor being inoculated with a booster dose of Covid-19 vaccine, at Ganga Ram Hospital, in New Delhi. (Amal KS/HT Photo)
Published on Feb 02, 2022 10:21 AM IST

Zydus Covid-19 vaccine hit by delay in supply

Zydus was expected to supply the first batch of its Covid-19 vaccine to the central government around the end of December last year.

Chennai, Jan 18 (ANI): A beneficiary receives a precautionary dose of the COVID-19 vaccine during a door-to-door vaccination drive, in Chennai on Tuesday. (ANI Photo) (L. Anantha Krishnan)
Chennai, Jan 18 (ANI): A beneficiary receives a precautionary dose of the COVID-19 vaccine during a door-to-door vaccination drive, in Chennai on Tuesday. (ANI Photo) (L. Anantha Krishnan)
Updated on Jan 19, 2022 05:12 AM IST

Zydus’s needle-free Covid vaccine may be introduced next week

According to the company, the Centre has placed an order of 10 million vaccine doses, at ₹265 per dose

Beneficiaries receive Covid-19 vaccine shots at a vaccination centre in Thane on Thursday. The Centre announced that Zydus Cadila’s Covid-19 vaccine ZyCoV-D will initially be used in districts in seven states. (PTI)(HT_PRINT)
Beneficiaries receive Covid-19 vaccine shots at a vaccination centre in Thane on Thursday. The Centre announced that Zydus Cadila’s Covid-19 vaccine ZyCoV-D will initially be used in districts in seven states. (PTI)(HT_PRINT)
Updated on Dec 17, 2021 04:31 AM IST

7 states to use Zydus in adults for now: Centre

Zydus Cadila’s Covid-19 vaccine ZyCoV-D will initially be used in districts in 7 states having low first dose coverage before it is rolled out nationwide, the Union health ministry said on Thursday.

Beneficiaries receive Covid-19 vaccine shots at a vaccination centre in Thane on Thursday. The Centre announced that Zydus Cadila’s Covid-19 vaccine ZyCoV-D will initially be used in districts in seven states. (PTI)
Beneficiaries receive Covid-19 vaccine shots at a vaccination centre in Thane on Thursday. The Centre announced that Zydus Cadila’s Covid-19 vaccine ZyCoV-D will initially be used in districts in seven states. (PTI)
Updated on Dec 03, 2021 12:39 AM IST

Zydus Cadila to supply 10 mn doses of Covid-19 jab to Centre by December: Report

The Centre placed an initial order for 10 million dose of ZyCoV-D with the Ahmedabad-based firm. The initial batch will be used only for adults.

Zydus Cadila Covid-19 vaccine (File Photo)
Zydus Cadila Covid-19 vaccine (File Photo)
Published on Nov 18, 2021 10:22 PM IST

Zydus jab cleared for kids to cost govt 265

The price is a significant reduction from the ₹1,900 the company initially quoted for the regimen of the indigenously-developed Covid-19 vaccine that is the world’s first plasmid DNA-based one.

An Ahmedabad-based drug maker— Zydus Cadila — has manufactured ZyCoV-D, the second indigenous vaccine after Covaxin.(HT_PRINT)
An Ahmedabad-based drug maker— Zydus Cadila — has manufactured ZyCoV-D, the second indigenous vaccine after Covaxin.(HT_PRINT)
Updated on Nov 09, 2021 01:46 AM IST

Govt to buy one crore doses of Zydus Cadila's needle-free Covid-19 vaccine

ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above. It received emergency use authorisation from the drug regulator on August 20.

ZyCov-D is a three-dose vaccine whose second and third doses are to be taken 28 and 56 days respectively after the first one.(Pixabay)
ZyCov-D is a three-dose vaccine whose second and third doses are to be taken 28 and 56 days respectively after the first one.(Pixabay)
Published on Nov 07, 2021 02:29 PM IST

ZyCoV-D nears inclusion in vaccination drive as Centre orders 10 million doses

According to reports, the indigenous, Zydus Cadila-developed jab is likely to be included this month, and will initially be administered only to adults.

Representative Image 
Representative Image 
Published on Nov 07, 2021 01:57 PM IST

Zydus Cadila agrees to cut price per dose of its Covid vaccine to 265: Report

The Ahmedabad-based company had earlier proposed ₹1900 for the regimen, which comprises three doses of ZyCoV-D.

Representative Image
Representative Image
Published on Oct 31, 2021 04:44 PM IST

Covid-19 vaccination for children depends on supply situation: VK Paul

Niti Aayog member (health) VK Paul said that the preparation for incorporating Zydus Cadila’s Covid-19 vaccine – ZyCoV-D, approved for emergency use in people aged 12 and above, is “proceeding well.”

Niti Aayog member (health) VK Paul cautioned against the loosening of guard against Covid-19, saying it will not be fair to say that the “worst is over
Niti Aayog member (health) VK Paul cautioned against the loosening of guard against Covid-19, saying it will not be fair to say that the “worst is over" in India.
Published on Oct 17, 2021 09:42 PM IST

Centre begins training for use of Zydus vaccine

“Preparation for the roll-out of Zydus vaccine is currently on; training is being imparted to those involved in giving the shot at various levels,” said VK Paul, member (health), Niti Aayog.

A medic administers a dose of Covid-19 vaccine to shopkeepers outside a Goddess Kali temple during a special vaccination drive, in Jammu, on Tuesday. (PTI)
A medic administers a dose of Covid-19 vaccine to shopkeepers outside a Goddess Kali temple during a special vaccination drive, in Jammu, on Tuesday. (PTI)
Updated on Oct 08, 2021 03:47 AM IST

Why Zydus Cadila vaccine rollout delayed? VK Paul points towards needle-free jet

Dr VK Paul, Niti Aayog member (Health), told a media briefing that an applicator will be used for the first time in India to administer the Covid-19 shots.

In August, Zydus Cadila received the emergency use authorisation from the drug controller general of India for its Covid vaccine ZyCoV-D.(AFP)
In August, Zydus Cadila received the emergency use authorisation from the drug controller general of India for its Covid vaccine ZyCoV-D.(AFP)
Published on Oct 07, 2021 06:06 PM IST

Zydus Cadila gets DGCI nod for phase III trial of two-dose Covid-19 vaccine

Zydus Cadila had started testing a two-dose regime of the vaccine with 3 milligrams in each dose soon after being granted an emergency use authorisation

ZyCoV-D, the first DNA vaccine, is also the first indigenously developed vaccine that has been trialled in children.(AFP)
ZyCoV-D, the first DNA vaccine, is also the first indigenously developed vaccine that has been trialled in children.(AFP)
Published on Oct 05, 2021 05:49 PM IST

Zydus Covid vaccine price continues to be key hurdle in Centre nod

ZyCoV-D is the first Indian vaccine to have shown to be safe and efficacious in children, and is the first to use DNA as a vector

A beneficiary receives Covid vaccine dose in New Delhi. The price of Zydus vaccine has remained an unresolved issue between the central government and the Ahmedabad-based Zydus Cadila. (PTI)
A beneficiary receives Covid vaccine dose in New Delhi. The price of Zydus vaccine has remained an unresolved issue between the central government and the Ahmedabad-based Zydus Cadila. (PTI)
Updated on Oct 05, 2021 03:22 AM IST

Zydus proposes 1,900 for its vaccine; talks on to cut price

However, the government is negotiating for a reduction in price and a final decision on it is likely to be taken this week.

ZyCoV-D received Emergency Use Authorisation from the drug regulator on August 20 making it the first vaccine to be administered in the age-group of 12 to 18.(File Photo)
ZyCoV-D received Emergency Use Authorisation from the drug regulator on August 20 making it the first vaccine to be administered in the age-group of 12 to 18.(File Photo)
Published on Oct 04, 2021 04:24 AM IST

Zydus Cadila Covid-19 jab soon to be part of India's vaccination programme: Govt

The government is aiming to launch the vaccines on October 2, on the birth anniversary of Mahatma Gandhi, after it decides the price of the three-dose ZyCoV-D vaccine.

ZyCov-D is a three-dose vaccine whose second and third doses are to be taken 28 and 56 days respectively after the first one.(Pixabay)
ZyCov-D is a three-dose vaccine whose second and third doses are to be taken 28 and 56 days respectively after the first one.(Pixabay)
Published on Sep 30, 2021 05:34 PM IST

Govt expert group may recommend inclusion of ZyCoV-D in India vaccination drive

The Centre could introduce the three-dose vaccine in a phased manner, with children with specified comorbidities receiving priority because they have the additional risk of severe infection.

A medical worker vaccinates a woman against Covid-19, in Amritsar. (Sameer Sehgal /HT)
A medical worker vaccinates a woman against Covid-19, in Amritsar. (Sameer Sehgal /HT)
Updated on Sep 27, 2021 05:10 AM IST

PM Modi announces world's first DNA vaccine for Covid-19 from global stage

Addressing the 76th United Nations General Assembly in New York, PM Modi said that the DNA vaccine can be administered to everyone above the age of 12.

An Ahmedabad-based drugmaker— Zydus Cadila — has manufactured ZyCoV-D, the second indigenous vaccine after Covaxin.
An Ahmedabad-based drugmaker— Zydus Cadila — has manufactured ZyCoV-D, the second indigenous vaccine after Covaxin.
Published on Sep 25, 2021 08:47 PM IST

'Plans afoot to add ZyCoV-D Covid-19 vaccine to national vaccination programme'

“The discussion on its pricing is ongoing, a decision will be taken soon. We are looking to include this vaccine in the national vaccination program,” Dr Paul said.

The Drugs Controller General of India (DCGI) gave its nod to the ZyCoV-D Covid-19 vaccine earlier on August 20.
The Drugs Controller General of India (DCGI) gave its nod to the ZyCoV-D Covid-19 vaccine earlier on August 20.
Published on Sep 14, 2021 04:25 PM IST

Zydus vaccine for kids likely to be available by Oct, says Centre

It still isn’t clear whether the vaccine will form part of the country’s ongoing drive to vaccinate all adults by the end of the year, or be reserved for the use of children

Secretary, Ministry of Health & Family Welfare, Rajesh Bhushan addresses a press conference on the actions taken, preparedness and updates on Covid-19 (including vaccination), in New Delhi on Thursday. (PTI)
Secretary, Ministry of Health & Family Welfare, Rajesh Bhushan addresses a press conference on the actions taken, preparedness and updates on Covid-19 (including vaccination), in New Delhi on Thursday. (PTI)
Updated on Aug 27, 2021 02:13 AM IST

When will ZyCov-D shot be available for children under 12?

“In the younger age group, we have not started them yet. We are working now with the regulators to work on a program to do a study for the younger age group as well," Zydus Group MD Dr Sharvil Patel said.

ZyCov-D became the sixth vaccine to be approved in India.(Representational image)
ZyCov-D became the sixth vaccine to be approved in India.(Representational image)
Published on Aug 21, 2021 08:37 PM IST

Zydus Cadila says will begin supply of its Covid-19 vaccine in mid-September

ZyCoV-D on Friday became India's second indigenous Covid-19 vaccine, and the sixth overall.

Representative Image
Representative Image
Published on Aug 21, 2021 03:00 PM IST

'Momentous feat': PM Modi on Zydus Cadila’s Covid vaccine getting approval

Zydus Cadila’s Covid-19 vaccine, ZyCoV-D, is the world's first DNA-based vaccine against the coronavirus which when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response

Zydus Cadila vaccine will be a three-dose vaccine and will have to be administered intradermally.(File Photo)
Zydus Cadila vaccine will be a three-dose vaccine and will have to be administered intradermally.(File Photo)
Published on Aug 20, 2021 10:36 PM IST

Zydus Cadila's 3-dose vaccine gets approval, 1st jab for children in India

If approved, ZyCoV-D will be India’s second indigenous coronavirus vaccine after Covaxin, and the sixth vaccine to be approved in the country so far

ZyCoV-D is a first of its kind DNA vaccine that produces the spike protein of the SARS-CoV-2 to elicit an immune response.(Reuters file photo. Representative image)
ZyCoV-D is a first of its kind DNA vaccine that produces the spike protein of the SARS-CoV-2 to elicit an immune response.(Reuters file photo. Representative image)
Published on Aug 20, 2021 06:22 PM IST

Zydus Cadila's Covid-19 vaccine likely to get emergency approval by this week

Zydus Cadila is planning to manufacture 100-120 million doses of the vaccine annually.

Zydus Cadila vaccine will be a three-dose vaccine and will have to be administered intradermally.(File Photo)
Zydus Cadila vaccine will be a three-dose vaccine and will have to be administered intradermally.(File Photo)
Published on Aug 09, 2021 01:39 PM IST

Zydus Cadila submits additional data on its Covid-19 vaccine to DCGI: Report

The Ahmedabad-based firm's vaccine candidate, ZyCoV-D, is expected to be approved in August.

A Covid-19 vaccination centre in Kolkata (ANI/used only for representative purpose)
A Covid-19 vaccination centre in Kolkata (ANI/used only for representative purpose)
Published on Jul 27, 2021 08:33 PM IST

Vaccine for kids to be available soon: Centre

The government told the court that the Drug Controller General of India has permitted Bharat Biotech to conduct clinical trials on children between the ages of 2 and 18 for its vaccine, Covaxin.

Zydus Cadila, which is developing DNA vaccines for Covid-19, has concluded its clinical trial for children between the ages of 12 and 18 years of age and is awaiting statutory permission.(Reuters)
Zydus Cadila, which is developing DNA vaccines for Covid-19, has concluded its clinical trial for children between the ages of 12 and 18 years of age and is awaiting statutory permission.(Reuters)
Updated on Jul 17, 2021 04:53 AM IST

'Need more data to make Zydus' anti-Covid shot available for children': VK Paul

Ahmedabad-based Zydus Cadila applied to DCGI on July 1, seeking emergency use authorisation for its vaccine to be administered to those above the age of 12.

NITI Aayog member Dr VK Paul (File Photo)
NITI Aayog member Dr VK Paul (File Photo)
Updated on Jul 16, 2021 07:22 PM IST

News updates from HT: Zydus Cadila's vaccine for kids may not be available soon

Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.

A vaccine against the coronavirus disease (Covid-19) for children that is being developed by Gujarat-based pharmaceutical company Zydus Cadila may not be available soon(File Photo)
A vaccine against the coronavirus disease (Covid-19) for children that is being developed by Gujarat-based pharmaceutical company Zydus Cadila may not be available soon(File Photo)
Published on Jul 12, 2021 12:50 PM IST

‘Efficacy 67%’: Zydus seeks nod for vaccine

Zydus Cadila said that this is the first coronavirus vaccine using a DNA plasmid in advanced trials, and the first in India to be tested in a large group of adolescents.

Zydus Cadila has planned to annually manufacture 100-120 million doses of ZyCoV-D, its DNA-based Covid-19 vaccine.(Reuters )
Zydus Cadila has planned to annually manufacture 100-120 million doses of ZyCoV-D, its DNA-based Covid-19 vaccine.(Reuters )
Updated on Jul 02, 2021 12:19 AM IST
SHARE
  • 1
  • 2
  • ...
Story Saved
×
Saved Articles
Following
My Reads
My Offers
Sign out
New Delhi 0C
Tuesday, December 06, 2022
Start 15 Days Free Trial Subscribe Now
Register Free and get Exciting Deals